Immunocore Holdings Ltd (IMCR) Live Share Price, Invest From India

Immunocore Holdings Ltd Stock Performance

as on May 14, 2026 at 4:14 am IST

Day's Low
Day's High
$28.68
Day's Price Range
$29.41
$28.67
-0.03%
Downside
2.58%
Upside
52 Week's Low
52 Week's High
$27.44
52-Week Price Range
$40.71
$28.67
4.29%
Downside
42.01%
Upside

Immunocore Holdings Ltd share price movements today

Previous Close: $29.30
Open: $29.31
Volume: 72.7K
Day's Low - High: $28.68 - $29.41
52 Week Low - High: $27.44 - $40.71

Immunocore Holdings Ltd Historical Returns

1 Month Return: -6.9 %
3 Month Return: -9.23 %
1 Year Return: + 2.63 %
3 Year Return: -52.33 %
5 Year Return: 0 %

Immunocore Holdings Ltd Stock Fundamentals & Key Indicators

Check Immunocore Holdings Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.5B

EPS (TTM)

0.0693

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

8.22%

PE Ratio (TTM)

PEG Ratio

EBITDA

-22.4M

Revenue (TTM)

400.0M

Profit Margin

-8.88%

Return On Equity TTM

-9.58%

Immunocore Holdings Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Immunocore Holdings Ltd with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Immunocore Holdings Ltd	BUY	$1.5B	NA	NA	-8.88%
Alnylam Pharmaceuticals Inc	BUY	$38.0B	119.7%	71.39	12.55%
BeiGene, Ltd.	NA	$32.7B	NA	71.44	8.94%
Vertex Pharmaceuticals Inc	BUY	$110.4B	109.14%	25.84	35.51%
Regeneron Pharmaceuticals Inc	BUY	$74.7B	39.88%	17.39	29.65%

Stock Returns calculator for Immunocore Holdings Ltd Stock including INR - Dollar returns

The Immunocore Holdings Ltd stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Immunocore Holdings Ltd investment value today

Current value as on today

₹1,12,703

Returns

₹12,703

(+12.7%)

Returns from Immunocore Holdings Ltd Stock

₹420 (+0.42%)

Dollar Impact

₹12,283 (+12.28%)

Analyst Recommendation on Immunocore Holdings Ltd Stock

Based on 24 analysts

BUY

91.67%

Buy

8.33%

Hold

0.00%

Sell

Based on 24 analysts, 91.67% of analysts recommend a 'BUY' rating for Immunocore Holdings Ltd. Average target price of $63.8

Immunocore Holdings Ltd Share Price Target

Get share price movements and forecasts by analysts on Immunocore Holdings Ltd.

What analysts predicted

55.06%UPSIDE

Target Price

$63.8

Current Price

$28.67

Analyzed by

24 Analysts

Target

$63.80

Immunocore Holdings Ltd target price $63.8, a slight upside of 55.06% compared to current price of $28.67. According to 24 analysts rating.

Indian Investors' Interest in Immunocore Holdings Ltd Stock

Search interest for Immunocore Holdings Ltd Stock has increased by 7% in the last 30 days, reflecting an upward trend in search activity.

Time period: April 13, 2026 to May 13, 2026

Change:7% versus previous 30 day period

Immunocore Holdings Ltd Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	70	89	75	80	84	93	97	103	77	106
Gross Profit	70	89	73	79	83	93	96	103	74	106
Operating Income	-13	-26	-16	-8	-19	-3	-14	-7	-14	7
EBITDA	-19	-19	-5	10	-15	9	-6	4	-8	8
Interest Expense	1	3	3	3	6	3	3	3	3	2
Depreciation	0	1	0	1	1	0	0	0	0	-
Income Before Tax	-20	-24	-10	6	-24	6	-9	0	-11	13
Income Tax Expense	-4	0	1	-2	-1	1	0	0	10	0
Net Income	-19	-31	-11	8	-23	5	-10	0	-22	12
Net Profit Margin	-28.12%	-34.66%	-15.41%	10.89%	-28.28%	5.35%	-10.51%	0.76%	-28.77%	12.16%

Immunocore Holdings Ltd Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	25	25	29	33	40	35	175	249	247	297
Gross Profit	25	25	29	-97	-60	35	169	248	242	291
Operating Income	-39	-90	-93	-118	-86	-129	-42	-47	-56	-33
EBITDA	-36	-85	-86	-111	-82	-123	-38	-40	-38	0
Interest Expense	-	-	0	3	3	5	5	4	18	12
Depreciation	-	-	6	9	8	7	6	5	4	3
Income Before Tax	-38	-87	-88	-81	-87	-133	-33	-48	-42	-14
Income Tax Expense	9	21	-16	22	-13	0	9	-4	-1	12
Net Income	-35	-88	-90	-136	-99	-177	-52	-55	-40	-26
Net Profit Margin	-140.50%	-343.13%	-302.82%	-404.89%	-246.04%	-493.45%	-30.13%	-22.17%	-16.45%	-8.88%

Immunocore Holdings Ltd Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-24	-11	8	-23	5	-10	0	-30	12
Operating Cash Flow	-4	23	21	-13	0	25	-4	-32	-13
Investing Cash Flow	0	-350	0	-3	9	-30	5	0	4
Financing Cash Flow	396	0	0	-51	2	3	1	4	0
Change in Cash	390	-327	32	-82	21	11	10	-30	-15

Immunocore Holdings Ltd Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-65	-71	-103	-74	-180	-52	-34	-51	-26
Operating Cash Flow	-81	-16	-101	-60	-143	-49	2	26	-7
Investing Cash Flow	-12	58	-4	0	-1	-2	-4	-355	-12
Financing Cash Flow	25	0	55	115	288	145	27	343	9
Change in Cash	-69	41	-50	55	144	81	31	13	8

Global Institutional Holdings in Immunocore Holdings Ltd

Funds	Holdings
TANG CAPITAL MANAGEMENT LLC	5.17%
Baker Bros Advisors LP	4.57%
Citigroup Inc	1.26%
Principal Financial Group Inc	1.02%
Point72 Asset Management, L.P.	0.99%

See all

Insights on Immunocore Holdings Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -22.27M → 12.97M (in $), with an average increase of 271.8% per quarter
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 77.42M → 106.67M (in $), with an average increase of 27.4% per quarter
NO EFFECT
Against Peers
In the last 1 year, BeOne Medicines Ltd has given 40.2% return, outperforming this stock by 37.6%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 32.2% return, outperforming this stock by 84.5%
NEGATIVE IMPACT
Price Dip
In the last 7 days, IMCR stock has moved down by -4.7%

About Immunocore Holdings Ltd

Immunocore Holdings plc, together with its subsidiaries, engages in the development and commercialization of immunomodulating medicines for patients with cancer, infectious diseases, and autoimmune disease in the United States, Europe, and internationally. The company offers KIMMTRAK for the treatment of unresectable or metastatic uveal melanoma. It also develops oncology programs, including tebentafusp which is in Phase 3 clinical trial for the treatment of advanced cutaneous melanoma and adjuvant uveal melanoma; brenetafusp which is in Phase 3 clinical trial for the treatment of first-line advanced cutaneous melanoma and in Phase 1/2 clinical trial for the treatment of various tumor types; IMC-R117C which is in Phase 1/2 clinical trial for the treatment of advanced solid tumors, such as colorectal cancer; and IMC-P115C which is in Phase 1 clinical trial for patients with tumors that express PRAME. In addition, the company is involved in the development of IMC-M113V which is in Phase 1 clinical trial for a potential functional cure of human immunodeficiency virus; and IMC-I109V which is in Phase 1 clinical trial for a potential functional cure of hepatitis B virus. Further, it develops IMC-S118AI which is in pre-investigation stage for the treatment of type 1 diabetes; and IMC-U120AI which is in pre-investigation stage for the treatment of atopic dermatitis. The company was founded in 1999 and is headquartered in Abingdon, the United Kingdom.

Organisation	Immunocore Holdings Ltd
Headquarters	92 Park Drive, Abingdon, United Kingdom, OX14 4RY
Industry	Biotechnology
CEO	Dr. Bahija Jallal Ph.D.
E-voting on shares	Click here to vote

Key Management of Immunocore Holdings Ltd

Name	Title
Mr. Travis Alan Coy M.B.A.	CFO, Executive VP & Head of Corporate Development
Mr. John Trainer M.B.A.	SVP & Chief Operating Officer
Ms. Annelise Vuidepot Ph.D.	Senior VP, CTO and Research & UK Site Lead
Ms. Lily Margaret Hepworth	Executive VP, General Counsel & Company Secretary
Dr. Bahija Jallal Ph.D.	CEO & Executive Director
Mr. John Goll III	SVP, Finance & Chief Accounting Officer
Mr. Sean D. Buckley	VP & Chief Information Officer
Ms. Elizabeth Varki Jobes Esq., J.D.	Chief Compliance Officer
Mr. Sébastien Desprez	Vice President of Communications
Ms. Tina St. Leger	Executive VP & Chief Human Resources Officer

FAQs

What is Immunocore Holdings Ltd share price today?

Immunocore Holdings Ltd share price today is $28.67 as on May 13, 2026 at 10:44 pm IST. Immunocore Holdings Ltd share today touched a day high of $29.41 and a low of $28.68.

What is the 52 week high and 52 week low for Immunocore Holdings Ltd share?

Immunocore Holdings Ltd share touched a 52 week high of $40.71 on December 5, 2025 and a 52 week low of $27.44 on May 15, 2025. Immunocore Holdings Ltd stock price today i.e. May 13, 2026 at 10:44 pm IST is trending at $28.67,which is 29.58% down from its 52 week high and 4.48% up from its 52 week low.

What is Immunocore Holdings Ltd's market capitalisation today?

Immunocore Holdings Ltd market capitalisation is $0.00T as on May 13, 2026 at 10:44 pm IST.

How to invest in Immunocore Holdings Ltd Stock (IMCR) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Immunocore Holdings Ltd on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Immunocore Holdings Ltd Shares that will get you 0.0523 shares as per Immunocore Holdings Ltd share price of $28.67 per share as on May 13, 2026 at 10:44 pm IST.

What is the minimum amount required to buy Immunocore Holdings Ltd Stock (IMCR) from India?

Indian investors can start investing in Immunocore Holdings Ltd (IMCR) shares with as little as ₹95.705 or $1 (as of May 13, 2026 at 10:44 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹957.05 in Immunocore Holdings Ltd stock (as per the Rupee-Dollar exchange rate as on May 13, 2026 at 10:44 pm IST). Based on Immunocore Holdings Ltd share’s latest price of $28.67 as on May 13, 2026 at 10:44 pm IST, you will get 0.3488 shares of Immunocore Holdings Ltd. Learn more about fractional shares .